St. Jude Medical: Competitor’s Recall Clouds ICD Market Predictions
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical believes it is well positioned to continue increasing its share of the implantable cardioverter defibrillator market in 2008, even though it is too soon to predict the precise impact of competitor Medtronic's Sprint Fidelis ICD lead recall
You may also be interested in...
Boston Scientific Sees CRM Pipeline Aiding ICD Market Share Gains
Boston Scientific is highlighting recent and near-term product introductions as a key component of its plan to boost market share in its cardiac rhythm management business
Boston Scientific Sees CRM Pipeline Aiding ICD Market Share Gains
Boston Scientific is highlighting recent and near-term product introductions as a key component of its plan to boost market share in its cardiac rhythm management business
St. Jude Goes Wireless With Launch Of Promote RF And Current RF
St. Jude Medical joins the increasingly crowded wireless ICD and CRT-D market with the U.S. launch of two new wireless heart failure devices